Health News: [cancer]

Yahoo! Alerts

Yahoo! Health - My Alerts - Edit Alert

Tuesday, October 02, 2012 10:04 AM PDT

Celgene's Abraxane meets main goal in melanoma trial Reuters via Yahoo! Canada News Tue, 02 Oct 2012 06:29 AM PDT (Reuters) - Celgene Corp said on Tuesday that in a late-stage clinical trial, patients with metastatic melanoma who took its drug Abraxane lived for a longer period without getting worse than those who received the chemotherapy dacarbazine. Abraxane is currently approved to treat patients with breast cancer who have failed to respond to other treatments. Celgene is hoping to win approval to ... ArQule, Daiichi Sankyo discontinue lung cancer drug trial Reuters via Yahoo! Canada News Tue, 02 Oct 2012 06:24 AM PDT (Reuters) - Biotechnology company ArQule Inc and Japan's Daiichi Sankyo Co Ltd said they will discontinue a late-stage trial of their experimental lung cancer drug after an interim analysis showed it would not meet the main goal of improving overall survival. "This is their single-most important asset. The drug may be dead, which may leave the company trading down to cash," said Chad Messer, an ...

See more health stories that match my keyword Visit Yahoo! Health

You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.